161 related articles for article (PubMed ID: 14981543)
41. High-throughput molecular profiling of a P-cadherin overexpressing breast cancer model reveals new targets for the anti-cancer bacterial protein azurin.
Bernardes N; Ribeiro AS; Abreu S; Vieira AF; Carreto L; Santos M; Seruca R; Paredes J; Fialho AM
Int J Biochem Cell Biol; 2014 May; 50():1-9. PubMed ID: 24509127
[TBL] [Abstract][Full Text] [Related]
42. Bacterial cupredoxin azurin hijacks cellular signaling networks: Protein-protein interactions and cancer therapy.
Gao M; Zhou J; Su Z; Huang Y
Protein Sci; 2017 Dec; 26(12):2334-2341. PubMed ID: 28960574
[TBL] [Abstract][Full Text] [Related]
43. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53.
Yamada T; Goto M; Punj V; Zaborina O; Kimbara K; Das Gupta TK; Chakrabarty AM
Infect Immun; 2002 Dec; 70(12):7054-62. PubMed ID: 12438386
[TBL] [Abstract][Full Text] [Related]
44. Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity.
Goto M; Yamada T; Kimbara K; Horner J; Newcomb M; Gupta TK; Chakrabarty AM
Mol Microbiol; 2003 Jan; 47(2):549-59. PubMed ID: 12519204
[TBL] [Abstract][Full Text] [Related]
45. A peptide fragment of azurin induces a p53-mediated cell cycle arrest in human breast cancer cells.
Yamada T; Mehta RR; Lekmine F; Christov K; King ML; Majumdar D; Shilkaitis A; Green A; Bratescu L; Beattie CW; Das Gupta TK
Mol Cancer Ther; 2009 Oct; 8(10):2947-58. PubMed ID: 19808975
[TBL] [Abstract][Full Text] [Related]
46. Does azurin bind to the transactivation domain of p53? A Trp phosphorescence study.
Gabellieri E; Bucciantini M; Stefani M; Cioni P
Biophys Chem; 2011 Dec; 159(2-3):287-93. PubMed ID: 21885181
[TBL] [Abstract][Full Text] [Related]
47. Synergistic effect of granzyme B-azurin fusion protein on breast cancer cells.
Paydarnia N; Khoshtinat Nikkhoi S; Fakhravar A; Mehdiabdol M; Heydarzadeh H; Ranjbar S
Mol Biol Rep; 2019 Jun; 46(3):3129-3140. PubMed ID: 30937652
[TBL] [Abstract][Full Text] [Related]
48. Induction of apoptosis of azurin synthesized from P. aeruginosa MTCC 2453 against Dalton's lymphoma ascites model.
Ramachandran S; Mandal M
Biomed Pharmacother; 2011 Oct; 65(7):461-6. PubMed ID: 22000294
[TBL] [Abstract][Full Text] [Related]
49. Discovery of Azurin-Like Anticancer Bacteriocins from Human Gut Microbiome through Homology Modeling and Molecular Docking against the Tumor Suppressor p53.
Nguyen C; Nguyen VD
Biomed Res Int; 2016; 2016():8490482. PubMed ID: 27239476
[TBL] [Abstract][Full Text] [Related]
50. Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53.
Punj V; Das Gupta TK; Chakrabarty AM
Biochem Biophys Res Commun; 2003 Dec; 312(1):109-14. PubMed ID: 14630027
[No Abstract] [Full Text] [Related]
51. Modulation of cell death in human colorectal and breast cancer cells through a manganese chelate by involving GSH with intracellular p53 status.
Banerjee K; Das S; Majumder S; Majumdar S; Biswas J; Choudhuri SK
Mol Cell Biochem; 2017 Mar; 427(1-2):35-58. PubMed ID: 28012015
[TBL] [Abstract][Full Text] [Related]
52. Rusticyanin, a bacterial electron transfer protein, causes G1 arrest in J774 and apoptosis in human cancer cells.
Yamada T; Hiraoka Y; Das Gupta TK; Chakrabarty AM
Cell Cycle; 2004 Sep; 3(9):1182-7. PubMed ID: 15467448
[TBL] [Abstract][Full Text] [Related]
53. The functions of azurin of
Ghasemi-Dehkordi P; Doosti A; Jami MS
Saudi J Biol Sci; 2020 Sep; 27(9):2308-2317. PubMed ID: 32884412
[TBL] [Abstract][Full Text] [Related]
54. Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin.
Yamada T; Hiraoka Y; Ikehata M; Kimbara K; Avner BS; Das Gupta TK; Chakrabarty AM
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4770-5. PubMed ID: 15044691
[TBL] [Abstract][Full Text] [Related]
55. Interaction of an anticancer peptide fragment of azurin with p53 and its isolated domains studied by atomic force spectroscopy.
Bizzarri AR; Santini S; Coppari E; Bucciantini M; Di Agostino S; Yamada T; Beattie CW; Cannistraro S
Int J Nanomedicine; 2011; 6():3011-9. PubMed ID: 22162658
[TBL] [Abstract][Full Text] [Related]
56. Cross-talk between cancer and Pseudomonas aeruginosa mediates tumor suppression.
Choi JK; Naffouje SA; Goto M; Wang J; Christov K; Rademacher DJ; Green A; Stecenko AA; Chakrabarty AM; Das Gupta TK; Yamada T
Commun Biol; 2023 Jan; 6(1):16. PubMed ID: 36609683
[TBL] [Abstract][Full Text] [Related]
57. [Cytotoxicity and apoptosis of human osteosarcoma U2OS cells induced by recombinant soluble AZURIN].
Miao XD; Ye ZM; Yang DS; Xu RZ; Li WX; Tao HM
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 34(5):384-9. PubMed ID: 16216046
[TBL] [Abstract][Full Text] [Related]
58. Structural basis of bacterial effector protein azurin targeting tumor suppressor p53 and inhibiting its ubiquitination.
Hu J; Jiang W; Zuo J; Shi D; Chen X; Yang X; Zhang W; Ma L; Liu Z; Xing Q
Commun Biol; 2023 Jan; 6(1):59. PubMed ID: 36650277
[TBL] [Abstract][Full Text] [Related]
59. Anticancer Actions of Azurin and Its Derived Peptide p28.
Huang F; Shu Q; Qin Z; Tian J; Su Z; Huang Y; Gao M
Protein J; 2020 Apr; 39(2):182-189. PubMed ID: 32180097
[TBL] [Abstract][Full Text] [Related]
60. Structural studies on Laz, a promiscuous anticancer Neisserial protein.
Hashimoto W; Ochiai A; Hong CS; Murata K; Chakrabarty AM
Bioengineered; 2015; 6(3):141-8. PubMed ID: 25714335
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
